DKK461.50
0.33%
Copenhagen, Jun 27, 05:00 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Industry

Novonesis Stock price

DKK461.50
-4.70 1.01% 1M
+51.40 12.53% 6M
+53.80 13.20% YTD
+29.80 6.90% 1Y
+33.20 7.75% 3Y
+83.20 21.99% 5Y
+141.20 44.08% 10Y
+400.40 655.32% 20Y
Copenhagen, Closing price Fri, Jun 27 2025
+1.50 0.33%
ISIN
DK0060336014
Symbol
NSIS B
Industry

Key metrics

Basic
Market capitalization
DKK214.4b
Enterprise Value
DKK225.2b
Net debt
DKK10.8b
Cash
DKK1.9b
Shares outstanding
466.2m
Valuation (TTM | estimate)
P/E
58.34 | 33.24
P/S
5.85 | 6.73
EV/Sales
6.15 | 7.07
EV/FCF
42.44
P/B
2.57
Dividends
DPS
DKK6.20
Yield 1Y | 5Y
1.34% | 1.47%
Growth 1Y | 5Y
0.00% | 3.38%
Payout 1Y | 3Y
125.00% | 63.36%
Increased
0 Years
Financials (TTM | estimate)
Revenue
DKK36.6b | DKK31.9b
EBITDA
- | DKK12.0b
EBIT
DKK7.0b
Net Income
DKK3.7b | DKK6.5b
Free Cash Flow
DKK5.3b
Growth (TTM | estimate)
Revenue
- | 11.39%
EBITDA
- | 90.70%
EBIT
-
Net Income
- | 183.75%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
48.95%
EBITDA
- | 37.73%
EBIT
19.03%
Net
10.01% | 20.32%
Free Cash Flow
14.48%
Financial Health
Equity Ratio
73.55%
Return on Equity
2.74%
ROCE
6.73%
ROIC
4.94%
Debt/Equity
0.15
More
EPS
DKK7.91
FCF per Share
DKK11.38
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Novonesis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,915 stocks worldwide.

Novonesis Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Novonesis forecast:

17x Buy
74%
4x Hold
17%
2x Sell
9%

Analyst Opinions

23 Analysts have issued a Novonesis forecast:

Buy
74%
Hold
17%
Sell
9%

Financial data from Novonesis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
36,637 36,637
-
100%
- Direct Costs 18,704 18,704
-
51%
17,932 17,932
-
49%
- Selling and Administrative Expenses 7,294 7,294
-
20%
- Research and Development Expense 3,883 3,883
-
11%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 6,973 6,973
-
19%
Net Profit 3,669 3,669
-
10%

In millions DKK.

Don't miss a Thing! We will send you all news about Novonesis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Head office Denmark
CEO Ester Baiget
Website www.novozymes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today